Lilly is widening its legal push against the black market for its experimental obesity shot, which still has no approval.
Recap by typeshit. Post by Facebook on Facebook.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Two new plans keep one price at every dose, with no membership fee. Prescriptions come from five named 503A pharmacies, and the cheaper plan skips California.
The 80-week Lancet trial of 1,152 adults saw 47% on the 12 mg dose lose at least 20% of their weight, with more nausea and diarrhea than placebo.
Loading…